Charted
Wednesday, Nov. 18, 2026The business of health, by the numbers
Live trackersDeal tracker $7.07B raisedFDA clearances 293 510(k)s in OctoberForm D raises $839M in 30 daysNew trials 266 Phase 2/3 in 30 days
About

The business of health, by the numbers

What Charted covers, and how.

Charted covers the money and the rules that shape health care: who raised what and from whom, which companies are buying which, what FDA cleared this week, how much Medicare will pay next year, and how the insurers and health-tech companies that depend on those decisions are doing.

We write for the people who make those decisions: founders, investors, health-system and payer executives, and the business-development teams at device and drug companies.

Documents first

Most of what moves health care is written down somewhere public before it is written up anywhere else. A financing shows up in a Form D. A device decision shows up in FDA's 510(k) database. A payment change shows up in a final rule. We start from those records and from companies' own announcements, and every story lists the documents it was drawn from.

Trackers

Our trackers count the deals we report, FDA's 510(k) clearances, health-care Form D filings, and new industry-sponsored trials. Each one explains what it counts and links every record to its source.

What we don't cover

Charted is not medical advice and does not judge whether a product works. When we describe a device or a drug, we say what the company or regulator says it is for, and we attribute it.

Read how we report, see the masthead, or sign up for Charted Daily.

Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.